PLX-R18 (Avoplacel), a Placental Expanded Mesenchymal-like Stromal Cell Therapy Shows Favorable Safety and Appears to Improve Incomplete Hematopoietic Recovery after Hematopoietic Cell Transplantation (HCT)
Year: 2022
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: Case Western Reserve University, University of Kansas Medical Center, Technion – Israel Institute of Technology, Rambam Health Care Campus, University Hospitals Seidman Cancer Center, Baylor University Medical Center, Mayo Clinic, Hackensack University Medical Center, Hebrew University of Jerusalem, Hadassah Medical Center, Memorial Sloan Kettering Cancer Center, Pluristem Therapeutics (Israel), Shaare Zedek Medical Center, Bikur Cholim Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310125651